EOLS (Evolus, Inc.) Stock Financials & Earnings | Market Cap Arena

EOLS (Evolus, Inc.) Stock Financials & Earnings | Market Cap Arena

EOLSEvolus, Inc.

Mkt Cap$353M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Revenue (TTM)$295M

Net Income (TTM)-$52M

EPS (TTM)-$0.80

Free Cash Flow (TTM)-$60M

Gross Margin66.8%

Op. Margin-11.1%

Net Margin-17.5%

FCF Margin-20.3%

P/S Ratio (TTM)1.2x

P/E Ratio (TTM)—

YoY Rev Growth+10.8%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$42M	$30M	-$12M
Q2 23	$49M	$35M	-$15M
Q3 23	$50M	$35M	-$13M
Q4 23	$61M	$39M	-$9M
Q1 24	$59M	$41M	-$9M
Q2 24	$67M	$47M	-$8M
Q3 24	$61M	$43M	-$15M
Q4 24	$79M	$50M	-$2M
Q1 25	$69M	$47M	-$15M
Q2 25	$69M	$45M	-$10M
Q3 25	$69M	$46M	-$12M
Q4 25	$88M	$59M	$4M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	2.3x	—
Q2 23	2.1x	—
Q3 23	1.9x	—
Q4 23	1.7x	—
Q1 24	1.6x	—
Q2 24	1.5x	—
Q3 24	1.4x	—
Q4 24	1.3x	—
Q1 25	1.3x	—
Q2 25	1.3x	—
Q3 25	1.2x	—
Q4 25	1.2x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$21M	-$21M
Q2 23	-$13M	-$13M
Q3 23	-$924K	-$1M
Q4 23	$813K	$452K
Q1 24	-$11M	-$11M
Q2 24	-$6M	-$8M
Q3 24	-$6M	-$7M
Q4 24	$5M	$3M
Q1 25	-$16M	-$17M
Q2 25	-$25M	-$25M
Q3 25	-$15M	-$17M
Q4 25	$0	$0

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$511K
Q2 23	$8K
Q3 23	$539K
Q4 23	$361K
Q1 24	$797K
Q2 24	$1M
Q3 24	$1M
Q4 24	$1M
Q1 25	$2M
Q2 25	$688K
Q3 25	$2M
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+23.0%	+8.9%
Q2 23	+32.8%	+10.2%
Q3 23	+47.6%	+22.5%
Q4 23	+39.8%	+28.3%
Q1 24	+42.2%	+27.0%
Q2 24	+35.6%	+15.7%
Q3 24	+22.1%	+20.6%
Q4 24	+29.4%	+16.7%
Q1 25	+15.5%	+22.6%
Q2 25	+3.7%	+6.7%
Q3 25	+12.9%	+5.1%
Q4 25	+11.6%	+3.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$3M	7.9%
Q2 23	$4M	8.5%
Q3 23	$5M	9.2%
Q4 23	$4M	7.2%
Q1 24	$5M	8.6%
Q2 24	$6M	8.6%
Q3 24	$5M	8.5%
Q4 24	$6M	7.8%
Q1 25	$6M	8.7%
Q2 25	$4M	6.5%
Q3 25	$5M	7.4%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$1M	—	—	$37M
Q2 23	$6M	—	—	$41M
Q3 23	$2M	—	—	$43M
Q4 23	$7M	$36M	$7M	—
Q1 24	$2M	—	—	$45M
Q2 24	$2M	—	—	$50M
Q3 24	$2M	—	—	$53M
Q4 24	$2M	$42M	$9M	—
Q1 25	$2M	—	—	$57M
Q2 25	$2M	—	—	$57M
Q3 25	$2M	—	—	$53M
Q4 25	$3M	—	—	$55M

Revenue Segments

Quarter	Product	Service
Q1 23	$41M	$674K
Q2 23	$49M	$666K
Q3 23	$49M	$696K
Q4 23	$61M	$328K
Q1 24	$59M	$369K
Q2 24	$66M	$687K
Q3 24	$60M	$921K
Q4 24	$79M	—
Q1 25	$68M	$448K
Q2 25	$69M	$688K
Q3 25	$69M	—
Q4 25	$89M	$1M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$31M	$0	$31M
Q2 23	$42M	$0	$42M
Q3 23	$39M	$0	$39M
Q4 23	$63M	$0	$63M
Q1 24	$97M	$0	$97M
Q2 24	$94M	$0	$94M
Q3 24	$85M	$0	$85M
Q4 24	$87M	$0	$87M
Q1 25	$68M	$0	$68M
Q2 25	$62M	$0	$62M
Q3 25	$44M	$0	$44M
Q4 25	$54M	$0	$54M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	56M	+0.4%
Q2 23	57M	+0.8%
Q3 23	57M	+0.2%
Q4 23	57M	+0.4%
Q1 24	59M	+2.7%
Q2 24	63M	+6.7%
Q3 24	63M	+0.7%
Q4 24	63M	+0.3%
Q1 25	64M	+0.5%
Q2 25	65M	+1.3%
Q3 25	65M	+0.3%
Q4 25	64M	-0.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 15	—	—
FY 16	—	—
FY 17	$0	21
FY 18	$0	70
FY 19	$149K	235
FY 20	$475K	119
FY 21	$597K	167
FY 22	$691K	215
FY 23	$740K	273
FY 24	$802K	332
FY 25	$883K	334